SOX9 in cartilage development and disease

230Citations
Citations of this article
175Readers
Mendeley users who have this article in their library.
Get full text

Abstract

SOX9 is a pivotal transcription factor in chondrocytes, a lineage essential in skeletogenesis. Its mandatory role in transactivating many cartilage-specific genes is well established, whereas its pioneer role in lineage specification, which along with transactivation defines master transcription factors, remains to be better defined. Abundant, but yet incomplete evidence exists that intricate molecular networks control SOX9 activity during the multi-step chondrogenesis pathway. They include a highly modular genetic regulation, post-transcriptional and post-translational modifications, and varying sets of functional partners. Fully uncovering SOX9 actions and regulation is fundamental to explain mechanisms underlying many diseases that directly or indirectly affect SOX9 activities and to design effective disease treatments. We here review current knowledge, highlight recent discoveries, and propose new research directions to answer remaining questions.

Cite

CITATION STYLE

APA

Lefebvre, V., Angelozzi, M., & Haseeb, A. (2019, December 1). SOX9 in cartilage development and disease. Current Opinion in Cell Biology. Elsevier Ltd. https://doi.org/10.1016/j.ceb.2019.07.008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free